Safety and long-term outcome of a new concept for surgical adhesion-reduction strategies (Prevadh): a prospective, multicenter study.

Jean-Yves Mabrut Jean-Pierre Favre 1 Bruno Desrousseaux Jacques Chipponi Jean-Pierre Arnaud 2 Jacques Domergue 3 J. P. Duffas Gilles Fourtanier 4 Jean-Bernard Flament 5 Christian Gouillat Stéphane Berdah Georges Mantion 6 Pierre-Louis Fagniez Gérard Champault Jacques Baulieux
1 I2MR - Institut de médecine moléculaire de Rangueil
2 TELEMME - Temps, espaces, langages Europe méridionale-Méditerranée
3 ESPACE - Études des Structures, des Processus d’Adaptation et des Changements de l’Espace
4 Chirurgie Générale et Digestive [Purpan]
5 PhLAM - Laboratoire de Physique des Lasers, Atomes et Molécules - UMR 8523
6 WHO Collaborating Center on Prevention and Treatment of Human Echinococcosis
Abstract : BACKGROUND/AIMS: No agent has been consistently effective in preventing formation of peritoneal adhesions and postoperative bowel obstruction after abdominal surgery. The aim of this prospective multicenter study was to assess clinical safety and efficiency of a new adhesion-reduction barrier METHODOLOGY: Between September 2000 and April 2001, Prevadh was used in 78 patients. Operative procedures included 25 hepatic resections, 7 cholecystectomies, 32 colonic resections, 7 protectomies, 3 colostomy or recovery of continuity, 1 gynaecologic surgery and 3 others. Eleven patients were operated on by laparoscopy and 67 by laparotomy. RESULTS: The overall incidence of abscesses and wound complications was 2.4% and 9% respectively. After a mean follow-up of 36 months (range: 4-51 months), no patients experienced adverse events related to the adhesion barrier. Surgical reoperative procedures were performed in 10 patients for unrelated causes and no bowel obstruction occurred within the protected area. CONCLUSIONS: This study confirmed the safety of Prevadh adhesion barrier and suggested that this resorbable barrier might provide prevention from adhesion formation on peritoneal injured surfaces. However, a large randomized controlled trial remains necessary to prove the real effectiveness of adhesion barriers on clinical long-term outcome.
Document type :
Journal articles
Complete list of metadatas
https://hal-ujm.archives-ouvertes.fr/ujm-00440357
Contributor : Patrick Mismetti <>
Submitted on : Thursday, December 10, 2009 - 2:34:12 PM
Last modification on : Tuesday, November 19, 2019 - 2:30:15 AM

Identifiers

  • HAL Id : ujm-00440357, version 1
  • PUBMED : 18613399

Collections

UNICE | CNRS | UNIV-FCOMTE | UNIV-ST-ETIENNE | MMSH | UNIV-AMU | TELEMME | UNIV-COTEDAZUR | UNIV-LILLE | UNIV-AVIGNON | UNIV-TLSE3

Citation

Jean-Yves Mabrut, Jean-Pierre Favre, Bruno Desrousseaux, Jacques Chipponi, Jean-Pierre Arnaud, et al.. Safety and long-term outcome of a new concept for surgical adhesion-reduction strategies (Prevadh): a prospective, multicenter study.. Hepato-Gastroenterology, Georg Thieme Verlag, 2008, 55 (82-83), pp.517-21. ⟨ujm-00440357⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

420

Contact

CCSD